Medical Device Industry

Found 5,570 articles

• Kelyniam Global Announces 510(k) Clearance for Integrated Fixation System for Custom Skull Implants

  5/24/2019

  Kelyniam Global, a maker of custom cranial and craniofacial implants, announced that it has received premarket approval from the Food and Drug Administration for a new 510 application that allows for unique modifications to their PEEK cranio-maxillofacial implant product line.

• Polarean Imaging Plc London Investor Symposium Wednesday 12 June 2019

  5/23/2019

  Polarean Imaging plc, the medical-imaging technology company, with a proprietary drug-device combination product for the magnetic resonance imaging market, announces it will be hosting a Capital Markets Day for all investors on Wednesday 12 June 2019.

• $2.7 Billion European Cardiac Surgery Market Expected to Grow 67% by 2024 Due to TAVI and TMVr Adoption – New Study by iData Research

  5/23/2019

  According to a new series of reports by iData Research, the European cardiac surgery device market is valued at $2.7 billion USD, and is expected to grow at a CAGR of 11.5% to reach $4.5 billion by 2024.

• Corindus CorPath GRX System Successfully Used in Live Complex Robotic-Assisted Coronary Intervention at EuroPCR 2019

  5/23/2019

  Case broadcast live to thousands of EuroPCR attendees from Clinique Pasteur in France

• Initial Study of the Minimally Invasive RheOx™ Device Demonstrates Positive Results for Chronic Bronchitis Patients

  5/23/2019

  Gala Therapeutics, Inc. announced new results from the initial study of its investigational RheOxTM device, demonstrating the safety and feasibility of Bronchial RheoplastyTM therapy to provide clinical benefit to patients with chronic bronchitis.

• LivaNova to Present at the Jefferies Healthcare Conference

  5/23/2019

  LivaNova PLC announced Damien McDonald, Chief Executive Officer, and Thad Huston, Chief Financial Officer, will present at the Jefferies Healthcare Conference on Tuesday, June 4 in New York at 11 a.m. Eastern Time.

• New Tiara and Reducer Data Presented in Several Presentations at the EuroPCR 2019 Conference in Paris

  5/23/2019

  Neovasc Inc. announced that new data for its Tiara™ transcatheter mitral valve replacement device and Neovasc Reducer™ device for the treatment of refractory angina were presented in several presentations at the EuroPCR 2019 Conference held this week in Paris, France.

• Apollo Endosurgery Announces DDW 2019 Clinical Highlights

  5/23/2019

  Apollo Endosurgery, Inc. announced highlights from DDW 2019 which took place from May 18th to May 21st in San Diego.

• Titan Medical Annual and Special Meeting Scheduled for Wednesday, May 29, 2019

  5/22/2019

  Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in single-port minimally invasive surgery (“MIS”), announces that its 2019 Annual and Special Meeting is scheduled for Wednesday, May 29, 2019 at 12:00 p.m.

• ControlRad™ Announces FDA Clearance and Launch of the Only Radiation Reduction Technology that Integrates into Mobile C-arms

  5/22/2019

  ControlRad, Inc., a privately held medical technology company focused on dramatically reducing unnecessary radiation exposure during fluoroscopically guided procedures, today announced that the U.S. Food and Drug Administration (FDA) granted 510(k) clearance for its ControlRad Trace and the company has initiated its commercial launch.

• Neovasc Announces Positive Two-Year Follow-up Safety and Efficacy Data for the Neovasc Reducer™ in a Peer Reviewed Article in the International Journal of Cardiology

  5/22/2019

  Neovasc Inc. announced that the International Journal of Cardiology has published a peer reviewed article regarding long term sustained efficacy and safety of the Reducer therapy in 50 patients suffering from refractory disabling angina.

• Smith & Nephew's OXINIUM™ Technology for Hips could save the US Health System an estimated $296 Million in 2020

  5/22/2019

  Smith & Nephew presented new data at the International Society for Pharmacoeconomics and Outcomes Research, Annual Meeting in New Orleans.

• Dexcom Announces Upcoming Conference Presentation - May 22, 2019

  5/22/2019

  DexCom, Inc. announced that management will present an update on Dexcom at the following upcoming investor conference

• CONMED Corporation Announces Quarterly Cash Dividend payable on July 5, 2019

  5/22/2019

  CONMED Corporation announced that its Board of Directors has declared a quarterly cash dividend of $0.20 per share, payable on July 5, 2019 to all shareholders of record as of June 14, 2019.

• CPAP Alternative Bongo® Rx - Hits the Market

  5/22/2019

  AirAvant Medical is proud to announce that its flagship product, the FDA cleared Bongo® Rx, is now available for patients requiring treatment of mild to moderate obstructive sleep apnea.

• Loftware Announces Enterprise Labeling Solution for the Medical Device Industry

  5/22/2019

  Loftware Spectrum® for Medical Device Purpose Built to Enable Compliance for UDI, EU MDR and 21 CFR Part 11

• Synaptive Medical Presented Mid-Field MRI Safety Data for Medical Device Implants at the 57th American Society of Neuroradiology (ASNR) 2019 Annual Meeting

  5/22/2019

  0.5 T MRI system may make diagnostically conclusive scans safer for patients with metal implants

• IME Medical Electrospinning launches MediSpin XL, a cutting-edge high-volume electrospinning production platform for Medical Devices - 21 May 2019

  5/21/2019

  Breakthrough in industrial large-scale manufacturing of well-defined biomedical fiber-based scaffolds for a wide variety of medical applications

• ClearFlow Names Michael Elniski VP of Global Sales

  5/21/2019

  ClearFlow, Inc., a medical device company based in Anaheim, California, has named Michael Elniski its new Vice President of Global Sales.

• ACTO Named One of the 2019 PM360 ELITE 100

  5/21/2019

  PM360, the premier information resource for marketing decision makers in the pharmaceutical, biotech, diagnostics, and medical device sectors, has named Parth Khanna, Kapil Kalra, and Kumar Erramilli as one of the 2019 PM360 ELITE 100 in the Entrepreneurs category.